Key result
Aortic stenosis is not linked to more intraoperative RBC transfusions versus insufficiency during valve replacement.
Why the study?
Does the presence of aortic-valve stenosis increase the need for intraoperative blood component transfusion in patients undergoing aortic-valve replacement?
Observational (n=136)
Does the presence of aortic-valve stenosis increase the need for intraoperative blood component transfusion in patients undergoing aortic-valve replacement?
The presence or severity of aortic-valve stenosis does not predict an increased need for intraoperative transfusion of blood components during aortic-valve replacement.
Answers are grounded in this paper and cite their sources.
No higher transfusion needs seen in aortic stenosis; leaves open whether valve pathology affects bleeding risk in larger studies.
OBJECTIVE: An association of aortic-valve stenosis and abnormal bleeding, particularly from gastrointestinal angiodysplasia, has been reported. In this setting, high-shear stress generated by the transvalvular gradient leads to a conformational change of plasmic von Willebrand factor, making this adhesive protein more susceptible for proteolytic cleavage. Consequently, highest-molecular weight multimers of the von Willebrand factor are degraded through a von Willebrand factor specific protease leading to impaired platelet-related haemostasis. METHODS AND RESULTS: To assess the role of aortic-valve stenosis as a factor predicting abnormal intraoperative bleeding in patients suffering from aortic-valve stenosis, we compared the number of intraoperatively administered blood components during aortic-valve replacement for aortic-valve stenosis (n = 50), aortic-valve insufficiency (n = 19) and combined aortic-valve defects (n = 67). As a result, the three subgroups did not differ significantly regarding the mean number of transfused red-blood cell units (0.94 +/- 1.36, 0.4 +/- 0.9, or 0.86 +/- 1.3, respectively) and plasma units (0.04 +/- 0.28, 0.21 +/- 0.71, or 0.15 +/- 0.61, respectively). None of the patients received platelet concentrates. A multivariate logistic regression model adjusted for age and gender did not show an influence of the presence and severity of aortic-valve stenosis on intraoperatively applied haemotherapy. CONCLUSION: Along with our findings, the presence or severity of aortic-valve stenosis does not predict an increased need for intraoperative transfusion of blood components. Thus, this cardiac defect does not seem to represent a major risk determinant for intraoperative bleeding despite the high prevalence of shear-stress induced von Willebrand factor abnormalities in this setting.
No takes yet. Share an insight, caveat, or question.
Sucker et al. (2010) conducted an observational in Aortic-valve stenosis (n=136). Aortic-valve stenosis vs. Aortic-valve insufficiency was evaluated on Mean number of transfused red-blood cell units. The presence of aortic-valve stenosis did not increase the mean number of intraoperatively transfused red-blood cell units during valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: